Research groups All groups >>

With a team of clinical and interventional cardiology researchers, the group's primary objective is to develop clinical research projects that address cardiovascular problems addressed in the health care system. The goal is to achieve results with practical applications for the National Health System in two major areas of research: acute coronary syndrome and heart failure.

There are 2 primary research lines:

• Acute coronary syndrome (ACS). In recent years studies have been conducted on risk stratification in this population, especially the subgroup of patients with chest pain and normal troponin. Future research will continue along these lines, including the potential of ultrasensitive troponin, and new projects are already studying the impact of comorbidity and fragility on ACS management and prognosis.
• Heart failure. The value of natriuretic peptides and CA125 as biomarkers for prognosis has been studied in patients hospitalized for acute heart failure. Future studies will explore drug therapy strategies guided by response to these biomarkers, as well as the usefulness of bioimpedance for risk stratification and as a guide in treatment decisions.

Latest publications

• Palau P, Núñez E, Dominguez E, Sanchis J, Núñez J Physical therapy in heart failure with preserved ejection fraction: A systematic review. Eur J Prev Cardiol 2016; 23: 4-13

  View abstract

• Sanchis J, Núñez E, Barrabés JA, Marín F, Consuegra-Sanchez L, Ventura S, Valero E, Roqué M, Bayés-Genís A, Del Blanco BG, Dégano I, Núñez J Randomized comparison between the invasive and conservative strategies in comorbid elderly patients with non-ST elevation myocardial infarction. Eur. J. Intern. Med. 2016; 35: 89-94

  View abstract

• Santas E, Sandino J, Chorro FJ, Méndez J, Miñana G, Núñez E, Sanchis J, Núñez J Prognostic implications of pericardial effusion in acute heart failure: Does size matter? Int. J. Cardiol. 2015; 184: 259-61

  View abstract

• García-Blas S, Núñez J, Mainar L, Miñana G, Bonanad C, Racugno P, Rodríguez JC, Moyano P, Sanchis J Usefulness and safety of a guide catheter extension system for the percutaneous treatment of complex coronary lesions by a transradial approach. Med Princ Pract 2015; 24: 171-7

  View abstract

• Santas E, García-Blas S, Miñana G, Sanchis J, Bodí V, Escribano D, Muñoz J, Chorro FJ, Núñez J Prognostic implications of tissue Doppler imaging-derived e/ea ratio in acute heart failure patients. Echocardiography 2015; 32: 213-20

  View abstract

• Núñez J, Rabinovich GA, Sandino J, Mainar L, Palau P, Santas E, Villanueva MP, Núñez E, Bodí V, Chorro FJ, Miñana G, Sanchis J Prognostic value of the interaction between galectin-3 and antigen carbohydrate 125 in acute heart failure. PLoS ONE 2015; 10: e0122360

  View abstract

• Regueiro A, Cuadrado-Godia E, Bueno-Betí C, Diaz-Ricart M, Oliveras A, Novella S, Gené GG, Jung C, Subirana I, Ortiz-Pérez JT, Roqué M, Freixa X, Núñez J, Escolar G, Marrugat J, Hermenegildo C, Valverde MA, Roquer J, Sanchis J, Heras M Mobilization of endothelial progenitor cells in acute cardiovascular events in the PROCELL study: time-course after acute myocardial infarction and stroke. J. Mol. Cell. Cardiol. 2015; 80: 146-55

  View abstract

• Núñez J, Miñana G, Santas E, Bertomeu-González V Cardiorenal Syndrome in Acute Heart Failure: Revisiting Paradigms. Rev Esp Cardiol (Engl Ed) 2015; 68: 426-35

  View abstract

• Núñez J, Bonanad C, Navarro JP, Bondanza L, Artero A, Ventura S, Núñez E, Miñana G, Sanchis J, Real J Differential Effect of Glycosylated Hemoglobin Value and Antidiabetic Treatment on the Risk of 30-day Readmission Following a Hospitalization for Acute Heart Failure. Rev Esp Cardiol (Engl Ed) 2015; 68: 852-60

  View abstract

• Bayés-Genís A, Avanzas P, Perez de Isla L, Sanchis J Acute heart failure: the unrecognized epidemic. Rev Esp Cardiol (Engl Ed) 2015; 68: 243-4

  View abstract

All publications